Ubrogepant

Synonyma:: MK-1602;(S)-N-((3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide;Ubuzhipan;Ubrogepant;Ubrogepant D5;Ubrogepant API;MK-1602 Ubrogepant;Ubrogepant, 10 mM in DMSO;MK1602,MK 1602,Ubrogepant,inhibit,Inhibitor,Calcitonin gene-related peptide receptor,CGRP Receptor;Spiro[6H-cyclopenta[b]pyridine-6,3'-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide, 1',2',5,7-tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2'-oxo-, (3'S)-

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 125

Ubrogepant Eigenschaften

SMILES: C12C[C@@]3(C(=O)NC4=NC=CC=C43)CC1=CC(C(N[C@H]1C[C@@H](C3=CC=CC=C3)[C@@H](C)N(CC(F)(F)F)C1=O)=O)=CN=2

Ubrogepant, is a new drug possible used for the treatment of migraine.

Synthesis route of Ubrogepant
Ubrogepant synthesis

Global( 125)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Zhengzhou Anbu Chem Co.,Ltd	+86-0371-88006763; +8615988602810	sales@anbuchem.com	China	3016	58
Jinan Carbotang Biotech Co.,Ltd.	+8615866703830	figo.gao@foxmail.com	China	8497	58
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19936	58
CONIER CHEM AND PHARMA LIMITED	+8618523575427	sales@conier.com	China	49979	58
SHANGHAI T&W PHARMACEUTICAL CO., LTD.	+86-021-61551413 +8618813727289	contact@trustwe.com	China	5745	58
TargetMol Chemicals Inc.	+1-781-999-5354; +17819995354	marketing@targetmol.com	United States	32467	58
Win-Win chemical CO., Limited	+86-0086-577-64498589 +86-15355981851	sales@win-winchemical.com	China	14304	58
HANGZHOU CLAP TECHNOLOGY CO.,LTD	86-571-88216897,88216896 13588875226	sales@hzclap.com	CHINA	6312	58
Dideu Industries Group Limited	+86-29-89586680 +86-15129568250	1026@dideu.com	China	28760	58
Zhejiang J&C Biological Technology Co.,Limited	+1-2135480471 +1-2135480471;	sales@sarms4muscle.com	China	10473	58

Ubrogepant
MK-1602 Ubrogepant
Spiro[6H-cyclopenta[b]pyridine-6,3'-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide, 1',2',5,7-tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2'-oxo-, (3'S)-
Ubrogepant API
Ubrogepant D5
MK-1602
MK1602,MK 1602,Ubrogepant,inhibit,Inhibitor,Calcitonin gene-related peptide receptor,CGRP Receptor
Ubuzhipan
Ubrogepant, 10 mM in DMSO
(S)-N-((3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide
1374248-77-7
1216913-27-2
C29H26F3N5O3
API
1374248-77-7